Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency

1

Review clinical trials related to Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

The purpose of this prospective registry is to characterize the natural history of ectonucleotide pyrophosphatase/phosphodiesterase1(ENPP1) Deficiency and the infantile-onset form of adenosine triphosphate (ATP) binding cassette transporter protein subfamily C member 6 (ABCC6) Deficiency longitudinally. The registry will prospectively gather information about the genetic, biochemical, physiological, anatomic, radiographic, and functional manifestations (including patient reported outcomes \[PROs\]) of each disease during routine, standard-of-care visits, with the aim of developing a comprehensive understanding of the burden of illness and progressive nature of the disease.

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Inozyme PharmaUpdated: Dec 22, 2025Locations: 14Duration: 10 Years
Eligibility criteria

Must provide written or electronic consent after the nature of the registry has... [+3]

Participant or their legally designated representative does not have the cogniti... [+2]